What is the recommended way to increase the dose of atomoxetine (Strattera) in an adult patient without severe cardiovascular disease, uncontrolled hypertension, narrow‑angle glaucoma, or serious liver impairment?

How to Raise Strattera (Atomoxetine) Dose

In adults without contraindications, start atomoxetine at 40 mg daily and increase after a minimum of 3 days to the target dose of 80 mg daily, administered either as a single morning dose or split into morning and late afternoon/evening doses 1.

Initial Dosing Strategy

The FDA-approved titration schedule for adults is straightforward:

• Starting dose: 40 mg/day
• Wait minimum 3 days before increasing
• Target dose: 80 mg/day (reached after the initial 3-day period)
• Maximum dose: 100 mg/day (only after 2-4 additional weeks if optimal response not achieved at 80 mg) 1

Dosing Schedule Options

You have flexibility in how to administer the daily dose:

• Once daily in the morning, OR
• Split dosing: evenly divided between morning and late afternoon/evening 1

Critical Timing Consideration

Allow 4-6 weeks at the target dose of 80 mg/day before judging efficacy 2. This is a common pitfall—many clinicians prematurely conclude the medication is ineffective without adequate time at therapeutic dosing. Real-world data show adults are frequently underdosed at approximately 60 mg/day average, which is subtherapeutic 2.

Slower Titration to Minimize Side Effects

While the FDA label permits rapid titration (3 days), gastrointestinal symptoms and initial somnolence are particularly problematic if dosage is increased too rapidly 3. Research demonstrates that slower titration over 1-2 weeks with twice-daily dosing reduces early adverse events:

• Slower titration (over ≥2 weeks) with twice-daily dosing showed lower rates of decreased appetite (8.0% vs 14.3%) and somnolence (4.2% vs 14.3%) compared to fast 3-day titration 4
• Consider this approach if the patient is particularly sensitive to side effects

When to Push to Maximum Dose

Only increase to 100 mg/day if:

1. Patient has been at 80 mg/day for 2-4 additional weeks
2. Response remains suboptimal
3. The 80 mg dose is well-tolerated 1

There is no evidence supporting increased effectiveness at doses higher than 100 mg 1.

Special Dosing Adjustments

If Patient is Taking CYP2D6 Inhibitors

Strong CYP2D6 inhibitors (paroxetine, fluoxetine, quinidine) significantly elevate atomoxetine levels:

• Start at 40 mg/day
• Only increase to 80 mg/day after 4 weeks if symptoms don't improve AND initial dose is well-tolerated 1

Hepatic Impairment

• Moderate hepatic impairment: Reduce initial and target doses to 50% of normal
• Severe hepatic impairment: Reduce to 25% of normal 1

Monitoring Requirements

Before and during dose escalation, monitor for:

• Cardiovascular parameters: Atomoxetine increases heart rate and blood pressure 3
• Suicidal ideation: Particularly during dose changes, though this risk is primarily documented in children/adolescents, not adults 5
• Gastrointestinal symptoms: Nausea, decreased appetite (dose-dependent) 3

Obtain cardiac history before initiating; if risk factors present, consider ECG 3.

Common Pitfalls to Avoid

1. Underdosing: Don't settle for 60 mg/day—push to the 80 mg target unless side effects prevent it 2
2. Premature discontinuation: Wait the full 4-6 weeks at target dose before declaring treatment failure 2
3. Too-rapid titration: If GI side effects emerge, consider slower escalation over 1-2 weeks 4
4. Ignoring drug interactions: SSRIs can double atomoxetine levels—adjust accordingly 5, 1

Discontinuation

Atomoxetine can be discontinued abruptly without tapering 1, unlike alpha-2 agonists which require gradual withdrawal.